Über uns

Development solutions for the road ahead.

Aptiv Solutions grew out of a first-hand recognition of the pressures and challenges facing drug and medical device developers – and the belief that a more dynamic paradigm for development is long overdue. Simply put, companies that continue to rely on conventional techniques risk missing out on rewarding opportunities.

So we’re focused on harnessing the power of adaptive clinical trials. To that end, we’ve combined the advanced capabilities and knowledge of subject-matter experts with the broad capabilities, deep process knowledge and flexibility of traditional CROs.

As a global company, we provide an extensive portfolio of innovative services, currently delivered by a worldwide team of more than 700 professionals. And since we don’t believe in standing still, we will evolve and adapt as we recognize obstacles and uncover opportunities – so that we can continue to help our clients succeed in whatever new development and regulatory landscape emerges in the years ahead.

The experience to get results. The insight to master change.

Aptiv Solutions brings together a talented and diverse group of skilled biopharmaceutical and medical device professionals, united around a single goal: helping our clients succeed in the challenging development landscape of the 21st century.

Decades of combined experience in some of the industry’s most well-known and well-respected pharmaceutical, biotech and device companies has given this team direct exposure to the pitfalls and unfulfilled promise of traditional development methods. Building on those lessons learned, they are now poised to apply their unique combination of skills to developing innovative approaches and delivering effective solutions designed for the decade ahead.

Aptiv Solutions at a glance

· Over 1800 clinical trials, utilizing internationally based staff

· At the forefront of adaptive trial design, simulation & execution

· More than 60 FDA approvals & 250 EU regulatory submissions

· Industry leader in Medical Device Development; more than 30 product approvals

· Deep therapeutic experience in Oncology, including a specialist oncology CRO in Japan

· Expert early phase development consulting

· Global drug development & trial management expertise

· Clinical operations encompass more than 700 professionals in North America, Europe, the Middle East & Japan